secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2022-05-11T23:59:59+00:00
Accession:  0001171520-22-000305
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro Q1 revenue $5.0M, up 25% YoY; raises FY2022 guidance to $21-22M
--------------------------------------------------------------------------------

- Record quarterly revenue of $5.0M, a 25% increase vs Q1 2021.
- Biologics and drug delivery revenue $2.2M (+30% YoY); functional neurosurgery revenue $2.2M (+17%).
- Operating expenses $7.1M, up from $4.8M in Q1 2021, driven by headcount and R&D.
- Cash position $49.7M at March 31, 2022 vs $54.1M at year-end 2021.
- Raised FY2022 revenue guidance to $21.0-22.0M, representing 30-35% growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000305/0001171520-22-000305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000305/eps10228_clpt.htm
  HTML page:      https://secwatch.observer/filing/0001171520-22-000305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer